PRABOTULINUMTOXINA-XVFS: 3,249 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
3,249
Total FAERS Reports
1
Deaths Reported
19
Hospitalizations
3,249
As Primary/Secondary Suspect
3
Life-Threatening
7
Disabilities
Prescription
Status
FDA Application: 761085 ·
First Report: 20180718 · Latest Report: 20250709
What Are the Most Common PRABOTULINUMTOXINA-XVFS Side Effects?
#1 Most Reported
Drug ineffective
1,332 reports (41.0%)
#2 Most Reported
Off label use
1,088 reports (33.5%)
#3 Most Reported
Therapeutic product effect decreased
714 reports (22.0%)
All PRABOTULINUMTOXINA-XVFS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,332 | 41.0% | 0 | 2 |
| Off label use | 1,088 | 33.5% | 1 | 5 |
| Therapeutic product effect decreased | 714 | 22.0% | 0 | 0 |
| Drug effect less than expected | 354 | 10.9% | 0 | 0 |
| Headache | 153 | 4.7% | 0 | 6 |
| Injection site pain | 99 | 3.1% | 0 | 0 |
| Patient dissatisfaction with treatment | 90 | 2.8% | 0 | 0 |
| Injection site swelling | 89 | 2.7% | 0 | 0 |
| Inappropriate schedule of product administration | 72 | 2.2% | 0 | 0 |
| Injection site erythema | 62 | 1.9% | 0 | 0 |
| Eyelid ptosis | 61 | 1.9% | 0 | 0 |
| Product preparation issue | 56 | 1.7% | 0 | 0 |
| Injection site pruritus | 45 | 1.4% | 0 | 0 |
| Product storage error | 39 | 1.2% | 0 | 0 |
| Dizziness | 33 | 1.0% | 0 | 3 |
| Vision blurred | 31 | 1.0% | 0 | 4 |
| Injection site papule | 27 | 0.8% | 0 | 0 |
| Vertigo | 21 | 0.7% | 0 | 0 |
| Therapeutic product effect incomplete | 19 | 0.6% | 0 | 0 |
| Pain | 18 | 0.6% | 0 | 0 |
Who Reports PRABOTULINUMTOXINA-XVFS Side Effects? Age & Gender Data
Gender: 90.7% female, 9.3% male. Average age: 46.2 years. Most reports from: US. View detailed demographics →
Is PRABOTULINUMTOXINA-XVFS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 0 |
| 2019 | 357 | 0 | 8 |
| 2020 | 76 | 0 | 1 |
| 2021 | 85 | 0 | 1 |
| 2022 | 116 | 0 | 0 |
| 2023 | 110 | 1 | 0 |
| 2024 | 81 | 0 | 4 |
| 2025 | 11 | 0 | 4 |
What Is PRABOTULINUMTOXINA-XVFS Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 2,750 |
| Skin wrinkling | 1,045 |
| Product use in unapproved indication | 152 |
| Off label use | 18 |
| Face lift | 8 |
| Skin cosmetic procedure | 5 |
PRABOTULINUMTOXINA-XVFS vs Alternatives: Which Is Safer?
PRABOTULINUMTOXINA-XVFS vs PRADAXA
PRABOTULINUMTOXINA-XVFS vs PRALATREXATE
PRABOTULINUMTOXINA-XVFS vs PRALSETINIB
PRABOTULINUMTOXINA-XVFS vs PRAMIPEXOLE
PRABOTULINUMTOXINA-XVFS vs PRAMIPEXOLE\PRAMIPEXOLE
PRABOTULINUMTOXINA-XVFS vs PRAMLINTIDE
PRABOTULINUMTOXINA-XVFS vs PRASTERONE
PRABOTULINUMTOXINA-XVFS vs PRASUGREL
PRABOTULINUMTOXINA-XVFS vs PRAVASTATIN
PRABOTULINUMTOXINA-XVFS vs PRAVASTATIN\PRAVASTATIN
Official FDA Label for PRABOTULINUMTOXINA-XVFS
Official prescribing information from the FDA-approved drug label.